Estrogen deficiency may account for lower circulating GH and insulin-like growth factor I (IGF-
I) concentrations in the menopause. Since the liver is the major source of circulating IGF-I …

To compare the effects of oral vs. transdermal estrogens on GH secretion and levels of
circulating insulin-like growth factor I (IGF-I) and IGF-binding protein-3 (IGFBP-3) in younger …

To determine if the mode of 17 beta-estradiol (E2) administration affects growth hormone
(GH) concentrations, eight postmenopausal women were studied under the following …

Prior studies in women have shown a positive correlation of endogenous estrogen levels
with spontaneous and stimulated GH secretion and basal insulin-like growth factor-I (IGF-I) …

We have determined whether oral estrogen reduces the biological effects of growth
hormone (GH) in GH-deficient (GHD) women compared with transdermal estrogen …

We prospectively studied two groups of GH-deficient patients during GH therapy based upon
exposure of the liver to elevated (oral estrogen) or not elevated (endogenous or …

OBJECTIVE Insulin like growth factor‐I (IGF‐I) levels in post‐menopausal women are
reduced by oral administration of the synthetic oestrogen ethinyl oestradiol but increased by …

To determine the effects of estrogen deficiency and replacement on GH secretion, we
measured the 22-h GH secretory pattern and response to 1 h of light exercise in 16 normal …

Evidence that oestrogen is involved in the regulation of the somatotrophic axis in adult
humans is provided by the observations that mean growth hormone (GH) levels are higher …

We have previously shown that exogenous estrogens exert route-dependent effects on
serum GH and insulin-like growth factor I (IGF-I) levels. IGF-I circulates as a ternary complex …